HOME >> BIOLOGY >> NEWS
European funding for research on biomolecular nanomachines

This release is also available in German

Scientists from the Max Planck Institute of Colloids and Interfaces, Potsdam, and from eight other scientific institutions in Germany, France, the Netherlands, and Italy have received 2 Million Euro from the European Union for research on "Active Biomimetic Systems". These systems involve two types of biomolecular nanomachines, growing filaments and stepping motors, which are able to generate force in the nanodomain. The research network, which is coordinated by Prof. Reinhard Lipowsky, will elucidate the molecular mechanism underlying this force generation and will explore new possibilities for the integration of these molecular machines into nano- and microsystems. The network was launched on May 1, 2005.

Biomimetic systems mimic or imitate certain aspects of biological systems. One astounding aspect of biological cells is their ability to undergo dramatic morphological transformations: they can adapt their shape in order to squeeze themselves through very narrow pores, they can extend long 'feet' in order to crawl along surfaces, and they can divide themselves up into two daughter cells. All of these transformation processes are based on two types of biomolecular nanomachines: growing filaments and stepping motors.

Both types of nanomachines are constructed from proteins but use distinct mechanisms for force generation. Filaments are rod-like structures with a thickness of about 10 nanometers but a length of many micrometers. One end of the filament grows by the addition of nanometer-sized building blocks and, in this way, generates a pushing force. Stepping motors are proteins with two identical 'legs', which are about 10 nanometers in size. When in contact with a filament, such a motor undergoes a certain conformational transformation, a so-called "power stroke", which enables the motor to generate a pulling
'"/>

Contact: Prof. Dr. Reinhard Lipowsky
Reinhard.Lipowsky@mpikg.mpg.de
49-331-567-9600
Max-Planck-Gesellschaft
3-Jun-2005


Page: 1 2 3

Related biology news :

1. European Science Foundations Forward Look reaches out beyond the endless frontiers
2. The UAB heads a European research project on proteases and pathological processes
3. Journalists can register now for ECCO 14 -- the European Cancer Conference
4. Climate changes brews trouble for marine life in European Seas, Marine Board-ESF report says
5. Early Europeans unable to stomach milk
6. European launch of International Polar Year 2007-2008
7. IDIBAPS participates in European Network on antibiotic resistances and hospital infections
8. European approval of HIV drug darunavir will provide a potent new option with Fuzeon
9. European launch of International Polar Year 2007-2008
10. European Federation of Biotechnology and Elsevier announce launch of biotechnology journal
11. Putting a face on the earliest modern Europeans

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/7/2017)... Feb. 7, 2017   MedNet Solutions , an ... spectrum of clinical research, is pleased to announce that ... its innovative, highly flexible and award winning eClinical solution, ... iMedNet is a proven Software-as-a-Service (SaaS) clinical ... Capture (EDC), but also delivers an entire suite of ...
(Date:2/3/2017)... WASHINGTON , Feb. 3, 2017 A ... Identity Strategy Partners, LLP (IdSP) . Designed to ... in the complex identity market, founding partners Mark ... nearly 35 combined years just in identity expertise that ... tank and non-profit leadership. The Crego-Kephart combined expertise has ...
(Date:1/31/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company ... of bacterial infections, today announced it has acquired ... Pro Bono Bio Ltd (PBB) to bolster its ... forms of Gram-negative bacteria.   The assets acquired have ... PBB group company. "The acquisition of ...
Breaking Biology News(10 mins):
(Date:2/23/2017)... Calif. , Feb. 23, 2017  MIODx ... license for two key immunotherapy technologies from the ... technology provides a method to monitor a patient ... as PD-L1 and CTLA-4.  The second license extends ... a patient is likely to have an immune-related ...
(Date:2/23/2017)... TX (PRWEB) , ... February 23, 2017 , ... ... Administration (FDA) de novo clearance to begin marketing the SPEAC® System, the Brain ... for adults at home or in healthcare facilities during periods of rest. A ...
(Date:2/23/2017)... ... February 23, 2017 , ... The Greater Gift Initiative, Inc , ... Compass Research . GGI's mission is to advance global health and highlight the ... need in honor of each clinical trial volunteer. The vision of GGI is to ...
(Date:2/23/2017)... USA, and CARDIFF, UK (PRWEB) , ... February ... ... international society for optics and photonics , have been named Fellows of the ... significant scientific and technical contributions in the multidisciplinary fields of optics, photonics, and ...
Breaking Biology Technology:
Cached News: